| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | — | -30.5% |
| R&D Expense | $525.6M | — | +47.9% |
| SG&A Expense | $376.1M | — | -4.6% |
| Operating Income | -$21.4M | — | -103.0% |
| Pre-tax Income | -$464.7M | — | -663.6% |
| Income Tax | -$70.6M | — | -519.0% |
| Net Income | -$394.1M | — | -700.7% |
| EPS (Basic) | -$1.49 | — | -673.1% |
| EPS (Diluted) | -$1.49 | — | -720.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.21B | -9.6% | +26.8% |
| Short-term Investments | $233.0M | -24.8% | — |
| Accounts Receivable | $296.2M | -3.5% | +20.9% |
| Current Assets | $19.68B | -3.5% | +12.8% |
| Total Assets | $28.85B | -2.8% | +32.8% |
| Current Liabilities | $9.19B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $182.7M | — | +200.0% |
| Investing Cash Flow | -$239.1M | — | -3.2% |
| Financing Cash Flow | -$864.9M | — | +3.2% |
| +32.6% |
| Long-term Debt | $7.20B | -0.1% | +69.9% |
| Total Liabilities | $15.37B | +3.3% | +36.5% |
| Stockholders' Equity | $13.48B | -8.9% | +28.8% |